QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Dai, Meng-di;  Wang, Yue-liang;  Fan, Jun;  Dai, Yang;  Ji, Yin-chun 收藏  |  浏览/下载：33/0  |  提交时间：2021/05/24 receptor tyrosine kinase  FGFR inhibitor  DW14383  antitumor activity   Meroterpenoids with diverse structures and anti-inflammatory activities from Rhododendron anthopogonoides 期刊论文 PHYTOCHEMISTRY, 2020, 卷号: 180, 页码: 11 作者:  Shi, Qing;  Li, Teng-Teng;  Wu, Yong-Mei;  Sun, Xin-Yu;  Lei, Chun 收藏  |  浏览/下载：34/0  |  提交时间：2020/12/24 Rhododendron anthopogonoides Maxim  Ericaceae  Meroterpenoids  Anthoponoids A-I  Daurichromene D  Anti-inflammation   SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7 作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei 收藏  |  浏览/下载：78/0  |  提交时间：2020/12/21 ROS1 kinase  ROS1 inhibitor  SAF-189s  lorlatinib  crizotinib resistance  G2032R mutant  NSCLC   Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020) 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 2 作者:  Wang, Yue-qin;  Shen, Ai-jun;  Sun, Jing-ya;  Wang, Xin;  Liu, Hong-chun 收藏  |  浏览/下载：12/0  |  提交时间：2020/07/01 Development and beam commissioning of a continuous-wave four-vane heavy ion radio-frequency quadrupole accelerator based on stable operation 期刊论文 NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2020, 卷号: 949, 页码: 12 作者:  Ma, Wei;  Lu, Liang;  Sun, Lie-Peng;  Yang, Yao;  Sun, Liang-Ting 收藏  |  浏览/下载：17/0  |  提交时间：2022/01/19 CW RFQ  Stable operation  Conditioning  Beam commissioning